ArticleGenetics, selection, evolution : GSE2025
A 3' UTR polymorphism g.1618 G > A in the MAFA gene modulates miR-3678-3p binding and enhances meat production in sheep via the MAFA/GHR/JAK2 pathway.
Article in Genetics, selection, evolution : GSE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMAFA (musculoaponeurotic fibrosarcoma oncogene Family A) is a specific transcriptional activator of the insulin gene (INS), playing a critical role in regulating insulin secretion and thereby indirectly influencing growth and development in animals. Previously, MAFA's role in meat production remained speculative, despite its known function in endocrine regulation. However, our recent publication provides direct evidence linking MAFA to muscular phenotypes in sheep. These findings support a direct role for MAFA in muscle growth, complementing its canonical role in insulin-mediated growth regulation. To further investigate this proposition, we conducted genotype-phenotype association analyses to assess the potential impact of MAFA polymorphisms on meat production performance in sheep. In parallel, we employed a combination of dual-luciferase reporter assays, transcriptome profiling, and ChIP-PCR to dissect the underlying molecular mechanisms. These findings were further validated in ovine myoblasts.
resultsWe found that the g.1618 G/A polymorphism in the 3' UTR of the MAFA gene is associated with meat production in sheep. Individuals with the GG genotype exhibited a 36.9% higher proportion of longissimus dorsi muscle mass compared to those with the AA genotype. Further analysis, including binding site prediction and dual-luciferase reporter assays, revealed that this mutation may regulate MAFA translation efficiency by altering the binding affinity of miR-3678-3p. Subsequently, ChIP-PCR experiments confirmed that the growth hormone receptor (GHR) gene is a direct target of the transcription factor MAFA. By conducting miR-3678-3p transfection and MAFA overexpression experiments in sheep myoblasts, we further validated the miR-3678-3p/MAFA/GHR regulatory axis and the classical GHR/JNK signaling pathway. These findings elucidate the molecular mechanism by which the g.1618 G/A polymorphism in the MAFA gene affects meat production in sheep, providing a novel molecular marker with potential application in molecular breeding for improved meat performance in sheep.
conclusionsIn summary, The G/A polymorphism at position g.1618 in the 3' UTR of the MAFA gene affects the binding of miR-3678-3p, thereby regulating the expression of the transcription factor MAFA at the post-transcriptional level. MAFA, in turn, directly influences the transcription of its target gene GHR, which affects JAK2 phosphorylation, ultimately regulating myoblast proliferation and muscle growth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.